Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma

Clinical trial NCT04833504 · COMPLETED

Trial details

NCT number: NCT04833504
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: COMPLETED
Study type: OBSERVATIONAL

Diffuse Large B-cell Lymphoma Mantle Cell Lymphoma Transformed Follicular Lymphoma Primary Mediastinal Large B-cell Lymphoma

Start date: 2018-09-22
Primary completion: 2023-09-22
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.